- Home
- HRMY vs DNUT Comparison
HRMY vs DNUT Comparison
Compare HRMY & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- DNUT
- Stock Information
- Founded
- HRMY 2017
- DNUT 1937
- Country
- HRMY United States
- DNUT United States
- Employees
- HRMY N/A
- DNUT N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- HRMY Health Care
- DNUT Consumer Staples
- Exchange
- HRMY Nasdaq
- DNUT Nasdaq
- Market Cap
- HRMY 2.0B
- DNUT 505.6M
- IPO Year
- HRMY 2020
- DNUT 2021
- Fundamental
- Price
- HRMY $31.70
- DNUT $2.92
- Analyst Decision
- HRMY Strong Buy
- DNUT Buy
- Analyst Count
- HRMY 9
- DNUT 8
- Target Price
- HRMY $54.22
- DNUT $10.23
- AVG Volume (30 Days)
- HRMY 627.2K
- DNUT 3.4M
- Earning Date
- HRMY 08-05-2025
- DNUT 08-07-2025
- Dividend Yield
- HRMY N/A
- DNUT 4.78%
- EPS Growth
- HRMY 13.13
- DNUT N/A
- EPS
- HRMY 2.62
- DNUT N/A
- Revenue
- HRMY $744,852,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- HRMY $20.10
- DNUT N/A
- Revenue Next Year
- HRMY $18.01
- DNUT $2.80
- P/E Ratio
- HRMY $12.13
- DNUT N/A
- Revenue Growth
- HRMY 20.62
- DNUT N/A
- 52 Week Low
- HRMY $26.47
- DNUT $2.50
- 52 Week High
- HRMY $41.61
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- HRMY 38.57
- DNUT 38.53
- Support Level
- HRMY $31.25
- DNUT $2.50
- Resistance Level
- HRMY $32.46
- DNUT $2.72
- Average True Range (ATR)
- HRMY 1.00
- DNUT 0.13
- MACD
- HRMY -0.37
- DNUT 0.03
- Stochastic Oscillator
- HRMY 11.69
- DNUT 33.33
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.